PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)

IDX:DGNS Revenue

PT Diagnos Laboratorium Utama Tbk had revenue of 45.11B IDR in the quarter ending June 30, 2026, with 13.67% growth. This brings the company's revenue in the last twelve months to 176.49B, up 11.06% year-over-year. In the year 2025, PT Diagnos Laboratorium Utama Tbk had annual revenue of 166.62B with 2.18% growth.

• Revenue (ttm): 176.49B
• Revenue Growth: +11.06%
• P/S Ratio: 1.90
• Revenue / Employee: 2.03B
• Employees: 87
• Market Cap: 335.50B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	166.62B	3.55B	2.18%
Dec 31, 2024	163.07B	17.38B	11.93%
Dec 31, 2023	145.70B	-47.19B	-24.47%
Dec 31, 2022	192.89B	-109.30B	-36.17%
Dec 31, 2021	302.18B	119.01B	64.97%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 30, 2026

Data Sources Report a data error